|Bid||338.75 x 800|
|Ask||339.00 x 2200|
|Day's range||333.40 - 340.33|
|52-week range||65.49 - 497.49|
|Beta (5Y monthly)||1.49|
|PE ratio (TTM)||40.12|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CAMBRIDGE, Mass., October 21, 2021--U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine
CAMBRIDGE, Mass., October 20, 2021--Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
CAMBRIDGE, Mass., October 14, 2021--Moderna announces FDA Advisory committee unanimously votes in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine in the U.S.